Casdin Capital, LLC sold WGS
August 22, 2025 · Form 4 insider transaction
Casdin Capital, LLC sold 500,000 shares of GeneDx Holdings Corp. at $120.90 per share, a transaction worth $60.45M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
500,000
Price
$120.90
Total value
$60.45M
InsiderCasdin Capital, LLC
Role—
CompanyGeneDx Holdings Corp. (WGS)
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateAugust 22, 2025
Filing dateAugust 22, 2025
Shares owned after3,007,164
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The securities are owned directly by the Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund ("Casdin"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP.